Cancer and Blood Disorders Research - $125.00

The Children’s team is committed to constantly evolving cancer and blood disorder care in pursuit of better outcomes for children.

At Children’s, our priority is research that can result in clinical benefits for children and teens. There are more than 100 actively enrolling research studies in the cancer and blood disorders program and the vast majority of these patients are enrolled in one or more clinical trials. They also benefit from Children’s rapid deployment of new information shared by researchers in cooperatives like the Children’s Oncology Group. The team has instant access to information about what’s working during clinical trials, so protocols can be constantly perfected.

Diagnosed with a rare genetic disorder at just six-weeks old, Ira wasn’t expected to live past his first birthday. Doctors and researchers developed a new treatment just for Ira and he is now approaching his third birthday making him the longest surviving patient with this form of Pompe’s disease in the world. “There was no treatment when my son was diagnosed...It was the doctors at Children’s who made it possible for him to be with me today.” ~Ja’Na, Ira's mom